- Home
- QBTS vs ARWR Comparison
QBTS vs ARWR Comparison
Compare QBTS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QBTS | ARWR |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.4B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | QBTS | ARWR |
|---|---|---|
| Price | $22.67 | $69.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 11 |
| Target Price | $32.80 | ★ $77.55 |
| AVG Volume (30 Days) | ★ 39.2M | 2.6M |
| Earning Date | 03-12-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $24,144,000.00 | ★ $829,448,000.00 |
| Revenue This Year | $196.28 | N/A |
| Revenue Next Year | $52.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 156.20 | ★ 23258.15 |
| 52 Week Low | $4.45 | $9.57 |
| 52 Week High | $46.75 | $76.76 |
Technical Indicators
Market Signals| Indicator | QBTS | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 38.98 | 58.44 |
| Support Level | $23.45 | $65.65 |
| Resistance Level | $25.69 | $68.80 |
| Average True Range (ATR) | 2.12 | 3.00 |
| MACD | -0.63 | -0.23 |
| Stochastic Oscillator | 5.79 | 82.97 |
Price Performance
Historical ComparisonAbout QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.